Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy.
García-Conde J, Lluch A, Martin M, Casado A, Gervasio H, De Oliveira C, De Pablo JL, Gorostiaga J, Girón GC, Cervantes A, et al. García-Conde J, et al. Among authors: de pablo jl, de oliveira c. Ann Oncol. 1994 Nov;5(9):854-7. doi: 10.1093/oxfordjournals.annonc.a059019. Ann Oncol. 1994. PMID: 7848890 Free article. Clinical Trial.
Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling.
Beristain E, Martínez-Bouzas C, Guerra I, Viguera N, Moreno J, Ibañez E, Díez J, Rodríguez F, Mallabiabarrena G, Luján S, Gorostiaga J, De Pablo JL, Mendizabal JL, Tejada MI. Beristain E, et al. Among authors: de pablo jl. Breast Cancer Res Treat. 2007 Dec;106(2):255-62. doi: 10.1007/s10549-006-9489-0. Epub 2007 Jan 30. Breast Cancer Res Treat. 2007. PMID: 17262179
CHEK2 1100delC is present in familial breast cancer cases of the Basque Country.
Martínez-Bouzas C, Beristain E, Guerra I, Gorostiaga J, Mendizabal JL, De-Pablo JL, García-Alegría E, Sanz-Parra A, Tejada MI. Martínez-Bouzas C, et al. Among authors: de pablo jl. Breast Cancer Res Treat. 2007 May;103(1):111-3. doi: 10.1007/s10549-006-9351-4. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063278 No abstract available.
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, Vassilopoulou-Sellin R, Yip CH, Egberts J, Mol-Arts M, Mulder R, van Os S, Beckmann MW; LIBERATE Study Group. Kenemans P, et al. Lancet Oncol. 2009 Feb;10(2):135-46. doi: 10.1016/S1470-2045(08)70341-3. Epub 2009 Jan 23. Lancet Oncol. 2009. PMID: 19167925 Free article. Clinical Trial.
13 results